In a sur­prise move, No­var­tis CEO Vas Narasimhan re­cruits top an­a­lyst Ron­ny Gal as new strat­e­gy, BD chief

Af­ter a long run ob­serv­ing No­var­tis and the rest of the Big Phar­ma world as a top an­a­lyst, Bern­stein’s Ron­ny Gal will now move in­to the up­per ech­e­lon of the Swiss gi­ant’s ex­ec­u­tive crew to take com­mand of their new­ly in­te­grat­ed strat­e­gy and growth team.

No­var­tis CEO Vas Narasimhan an­nounced the move ear­ly Tues­day with the Q1 num­bers, with the com­pa­ny high­light­ing the role Gal will play di­rect­ing deals, build­ing the pipeline and pri­or­i­tiz­ing pro­grams while po­si­tion­ing the com­pa­ny in a new ap­proach aimed at sig­nif­i­cant­ly im­prov­ing on their run­ner-up sta­tus in the all-im­por­tant US mar­ket.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER